Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker: Switch, Allorion and more
Alongside the new year, we've launched a new Fierce Biotech Fundraising Tracker.
Gabrielle Masson
,
Max Bayer
,
Annalee Armstrong
Mar 22, 2023 11:00am
Flare fires up with $123M series B and 3 Big Pharmas in tow
Mar 22, 2023 6:30am
Return of the megaround: Is biotech back from the brink?
Mar 21, 2023 7:00am
With $105M and Big Pharma backing, Mediar takes aim at fibrosis
Mar 15, 2023 8:21am
Why do so many biotechs face being kicked off the Nasdaq?
Mar 14, 2023 9:55am
HSBC keeps doors open at biotechs with UK SVB acquisition
Mar 13, 2023 8:30am
